Surgery Partners
SGRY
138 hedge funds and large institutions have $2.2B invested in Surgery Partners in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 22 closing their positions.
123% more capital inflows, than outflows
Capital inflows: $121M | Capital outflows: $54.1M
81% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 32
62% more call options, than puts
Call options by funds: $9.6M | Put options by funds: $5.89M
1.67% more ownership
Funds ownership: 102.75% → 104.42% (+1.7%)
1% more funds holding
Funds holding: 137 → 138 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cannell & Co
New York
|
+$17M |
| 2 |
Durable Capital Partners
Bethesda,
Maryland
|
+$14M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$12M |
| 4 |
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$9M |
| 5 |
Avidity Partners Management
Dallas,
Texas
|
+$8.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.2M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$4.43M |
| 4 |
Castleark Management
Chicago,
Illinois
|
-$3.58M |
| 5 |
Putnam Investments
Boston,
Massachusetts
|
-$2.58M |
SGRY Hedge Fund Activity: Q3 2022 in Review
138 of the 5,833 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q3 2022, worth a combined $2.2B — down 18% from $2.67B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of SGRY and 21 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 58 added.
The largest buyer was Cannell & Co, adding an estimated $17M. The largest seller was Point72 Asset Management, cutting an estimated $12.5M.
- 138 institutional investors held Surgery Partners (SGRY) as of Q3 2022, up from 137 in Q2 2022.
- Funds reported $2.2B of Surgery Partners stock for Q3 2022, down 18% quarter-over-quarter.
- 21 funds opened new Surgery Partners positions in Q3 2022 and 22 closed out, a net change of -1 holder.
- The largest Surgery Partners buyer in Q3 2022 was Cannell & Co, an estimated $17M added.
- The largest Surgery Partners seller in Q3 2022 was Point72 Asset Management, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2022.